DanCann Pharma A/S (NGM:DANCAN)
Sweden
· Delayed Price · Currency is SEK · Price in DKK 0.0018
0.00 (0.00%)
At close: Feb 21, 2025
DanCann Pharma Revenue
In the year 2024, DanCann Pharma had annual revenue of 7.76M DKK with 8.54% growth. DanCann Pharma had revenue of 1.35M in the quarter ending December 31, 2024, a decrease of -16.25%.
Revenue
7.76M DKK
Revenue Growth
+8.54%
P/S Ratio
0.97
Revenue / Employee
647.00K DKK
Employees
12
Market Cap
11.15M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 176.78B |
| Atlas Copco AB | 176.77B |
| AB Volvo | 526.82B |
| EQT AB | 30.40B |
| ASSA ABLOY AB | 150.16B |
| Skandinaviska Enskilda Banken AB | 81.00B |
| Hexagon AB | 61.89B |
| Telefonaktiebolaget LM Ericsson | 247.88B |